Mirdametinib | PD0325901 丨CAS 391210-10-9

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
10 mg	In-stock	$118.00	Visible after login	- +
50 mg	In-stock	$226.00	Visible after login	- +
100 mg	In-stock	$336.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

10 mg

In-stock

$118.00

Visible after login

- +

50 mg

In-stock

$226.00

Visible after login

- +

100 mg

In-stock

$336.00

Visible after login

- +

Product Overview

Product Name	Mirdametinib (PD0325901)
CAS	391210-10-9
Formula	C16H14F3IN2O4
MW	482.19
Appearance	White powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Mirdametinib, also known as PD-0325901, is a potent bioavailable and selective MEK inhibitor, which targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. MEK inhibitor PD325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1077

Mirdametinib (PD0325901)

391210-10-9 99+%